Peramivir
Catalog No.
A3709
Aeuraminidase inhibitor;antiviral drug
Featured Products
Peramivir is an experimental antiviral drug developed by BioCryst Pharmaceuticals for the treatment of influenza. It has been authorized for the emergency use of treatment of certain hospitalized patients with known or suspected 2009 H1N1 influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. From Wikipedia
| Physical Appearance | A solid |
| Storage | Store at -20°C |
| M.Wt | 328.41 |
| Cas No. | 330600-85-6 |
| Formula | C15H28N4O4 |
| Synonyms | RWJ 270201;Rapiacta;BCX 1812;RWJ-270201;RWJ270201;BCX-1812;BCX1812 |
| Solubility | ≥3.37 mg/mL in DMSO; ≥5.66 mg/mL in H2O with gentle warming and ultrasonic; ≥7.6 mg/mL in EtOH |
| Chemical Name | (1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid |
| SDF | Download SDF |
| Canonical SMILES | CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
Chemical structure
